急性缺血性卒中取栓术后强化与常规血压控制的系统评价与Meta分析
该系统评价与Meta分析纳入4项随机临床试验、1571例初始入组的大血管闭塞急性缺血性卒中取栓术后患者,比较强化与常规收缩压目标。强化降压组功能独立率更低(RR 0.81,95%CI 0.67-0.98);90天死亡(RR 1.18,95%CI 0.92-1.52)、症状性颅内出血(RR 1.12,95%CI 0.75-1.67)、低血压事件(RR 1.80,95%CI 0.37-8.76)无显著差异。作者结论认为取栓术后强化降压无获益且可能带来风险,在等待更多试验结果期间日常实践更倾向保守血压管理。
要点
- 取栓术后强化降压组功能独立率更低:RR 0.81(95%CI 0.67-0.98),该结局异质性 I2=13%、τ2=0.003。
- 90天死亡无显著差异:强化组 vs 常规组 RR 1.18(95%CI 0.92-1.52)。
- 症状性颅内出血无显著差异:RR 1.12(95%CI 0.75-1.67)。
- 低血压事件无显著差异:RR 1.80(95%CI 0.37-8.76)。
- 作者结论:取栓术后强化降压不产生获益、可能带来风险;等待更多试验期间日常实践更倾向保守血压管理策略。
适用人群与场景
- 大血管闭塞所致急性缺血性卒中、接受血管内取栓术(EVT)的患者。
- 纳入标准为比较取栓术后强化与常规收缩压目标的随机临床试验;排除非随机研究、观察性研究、非干预性试验、会议摘要、重复研究、数据重叠研究及非英语研究。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,检索PubMed、Embase、Web of Science、Scopus和Cochrane Library至2023年9月8日,遵循PRISMA报告规范,采用随机效应模型合并数据,使用修订版随机试验偏倚风险评估工具评价偏倚风险。
- 纳入4项随机临床试验、1571例初始入组患者。
- 主要结局功能独立率:强化降压组更低,RR 0.81(95%CI 0.67-0.98);该结局异质性 I2=13%、τ2=0.003。
- 90天死亡:RR 1.18(95%CI 0.92-1.52),无显著差异。
- 症状性颅内出血:RR 1.12(95%CI 0.75-1.67),无显著差异。
- 低血压事件:RR 1.80(95%CI 0.37-8.76),无显著差异。
- 其他结局异质性 I2=0、τ2=0。
证据类型、等级与局限
- 证据类型:随机临床试验的系统评价与Meta分析;采用修订版随机试验偏倚风险评估工具评价偏倚风险。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为取栓术后强化降压不产生获益且可能带来风险。
- 作者认为在等待更多正在进行的试验结果期间,血管内再通术后日常实践更倾向保守的血压管理策略。
指南或共识出处
- JAMA Netw Open 发表的系统评价与Meta分析(Intensive vs Conventional Blood Pressure Control After Thrombectomy in Acute Ischemic Stroke)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Endovascular thrombectomy (EVT) is standard treatment for acute ischemic stroke (AIS) due to large-vessel occlusion (LVO), but optimal post-EVT blood pressure (BP) control remains debated.
OBJECTIVE: To assess the association of different systolic BP targets following EVT with functional outcomes, mortality, and complications in patients with AIS due to LVO.
DATA SOURCES: Systematic review and meta-analysis of databases (PubMed, Embase, Web of Science, Scopus, and Cochrane Library) to September 8, 2023.
STUDY SELECTION: Inclusion criteria consisted of randomized clinical trials examining post-EVT management of systolic BP in patients with AIS and LVO comparing intensive vs conventional targets. Nonrandomized studies, observational studies, noninterventional trials, meeting abstracts, duplicate studies, studies with overlapping data, and non-English language studies were excluded. Two authors independently applied these criteria through a blinded review, with discrepancies resolved through consensus. The risk of bias in the included studies was assessed using the revised tool for assessing risk of bias in randomized trials.
DATA EXTRACTION AND SYNTHESIS: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guideline. Three authors extracted data regarding study characteristics, baseline patient data, and outcomes of interest. The pooled data were analyzed using a random-effects meta-analysis.
MAIN OUTCOMES AND MEASURES: Rates of functional independence, 90-day mortality, symptomatic intracranial hemorrhage, and hypotensive events.
RESULTS: A total of 4 randomized clinical trials with 1571 initially enrolled patients were included in the analysis. Lower functional independence rates were observed in the intensive control group (relative risk [RR], 0.81 [95% CI, 0.67-0.98]). No significant differences were found in 90-day mortality (RR, 1.18 [95% CI, 0.92-1.52]), symptomatic intracranial hemorrhage (RR, 1.12 [95% CI, 0.75-1.67]), or hypotensive events (RR, 1.80 [95% CI, 0.37-8.76]). There was minimal heterogeneity among the studies included in the functional independence outcome (I2 = 13% and τ2 = 0.003), which was absent among other outcomes (I2 = 0 and τ2 = 0).
CONCLUSIONS AND RELEVANCE: These findings suggest that intensive post-EVT BP reduction does not yield benefits and may carry risks. While awaiting the results of additional ongoing trials, a conservative BP management strategy after endovascular recanalization is favored in daily practice.
参考来源
- Ghozy S, Mortezaei A, Elfil M, et al. Intensive vs Conventional Blood Pressure Control After Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024. PMID: 38386320. doi:10.1001/jamanetworkopen.2024.0179
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。